| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/02/1995 | WO1995003413A1 High level expression, purification and refolding of the neisseria meningitidis outer membrane group b porin proteins |
| 02/02/1995 | WO1995003407A2 Oligonucleotides with activity against human immunodeficiency virus |
| 02/02/1995 | WO1995003406A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | WO1995003327A2 Peptides for neutralizing the toxicity of lipid a |
| 02/02/1995 | WO1995003325A1 Protegrins |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003313A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them |
| 02/02/1995 | WO1995003304A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/02/1995 | WO1995003070A1 Recombinant swinepox virus |
| 02/02/1995 | WO1995003069A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | WO1995003054A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | WO1995003051A1 Use of quinoline-3-carboxamide compounds for inhibiting the production of tumour necrosis factor (tnf) and/or for the treatment of septic shock |
| 02/02/1995 | WO1995003042A1 Method of inhibiting the replication of human immunodeficiency viruses with substituted azaspiranes |
| 02/02/1995 | WO1995002967A1 Viscous liquid xylitol compositions and method for preparing same |
| 02/02/1995 | WO1994026925A3 Processes for producing an enzyme |
| 02/02/1995 | WO1994026723A3 ras FARNESYL TRANSFERASE INHIBITORS |
| 02/02/1995 | CA2167843A1 Method of treating hiv with azaspiranes |
| 02/02/1995 | CA2167842A1 Method of inhibiting the replication of human immunodeficiency viruses with substituted azaspiranes |
| 02/02/1995 | CA2167821A1 New silylated benzylamine derivatives and their salts; process for producing the same and pharmaceutical compositions containing them |
| 02/02/1995 | CA2167808A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | CA2167805A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | CA2167677A1 Method for the high level expression, purification and refolding of the outer membrane group b porin proteins from neisseria meningitidis |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2166890A1 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | CA2166788A1 Protegrins |
| 02/01/1995 | EP0636627A1 Cephem compounds and antimicrobial agents |
| 02/01/1995 | EP0636378A1 Absorbable composite materials for use in the treatment of periodontal disease |
| 02/01/1995 | EP0636374A2 A spermicidal anti-viral lubricant composition |
| 02/01/1995 | EP0636372A1 Antiviral, antitumor, antimetastatic, immune system enhancing 7-thia-guanosine derivatives |
| 02/01/1995 | EP0636182A1 Antibodies for treatment and prevention of respiratory syncytial virus infection |
| 02/01/1995 | EP0636173A1 Treatment of hiv-associated immune thrombocytopenic purpura |
| 02/01/1995 | EP0636145A1 Synthetic polypeptides derived from the hiv envelope glycoprotein |
| 02/01/1995 | EP0636133A1 Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents |
| 02/01/1995 | EP0636124A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same |
| 02/01/1995 | EP0636030A1 pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
| 02/01/1995 | EP0636024A1 Potentiation of antimicrobial effects |
| 02/01/1995 | EP0500736B1 Recombinant vaccine for porcine pleuropneumonia |
| 02/01/1995 | CN1098107A Modified oligodeoxyribonucleotides, their preparation and their therapeutic use |
| 02/01/1995 | CN1098104A Carbapenem derivatives and their salts |
| 02/01/1995 | CN1098103A Novel pyridone carboxylic acid derivatives |
| 01/31/1995 | US5386041 Antibiotic |
| 01/31/1995 | US5386030 Chemical intermediates |
| 01/31/1995 | US5386010 Water-soluble, inhalable echinocandins; fungicides; antiprotozoa agents, yeasts |
| 01/31/1995 | US5385917 Carboxylic acid derivatives |
| 01/31/1995 | US5385911 Potent inhibitors of glycoprotein processing enzymes |
| 01/31/1995 | US5385909 Heterocyclic esters of rapamycin |
| 01/31/1995 | US5385908 Immunosuppressants, antiinflammatory agents |
| 01/31/1995 | US5385900 A 1H-1,4-diazepin-5-one-oxoquinoline carboxylic acids microbiocides especial against grampositive bacterial |
| 01/31/1995 | US5385899 Aminoalkyl-substituted 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes |
| 01/31/1995 | US5385891 Polysulfate of β-cyclodextrin derivative and process for preparing the same |
| 01/31/1995 | US5385735 Semduramicin premix |
| 01/31/1995 | CA1334180C Antibiotics r106 |
| 01/31/1995 | CA1334166C Antiviral preparation containing dideoxy-nucleosides |
| 01/29/1995 | CA2128954A1 Spermicidal anti-viral lubricant composition and method of using same |
| 01/27/1995 | CA2128742A1 Oil-based and water-based adjuvant mixture |
| 01/26/1995 | WO1995002697A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/26/1995 | WO1995002686A1 Redirection of cellular immunity by receptor chimeras |
| 01/26/1995 | WO1995002597A1 IMIDAZO[4,5-c]PYRIDIN-4-AMINES |
| 01/26/1995 | WO1995002594A1 Amide derivatives of 16-membered ring antibiotic macrolides |
| 01/26/1995 | WO1995002591A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | WO1995002583A1 Process for making hiv protease inhibitors |
| 01/26/1995 | WO1995002582A1 Cyclic hydrazine compounds |
| 01/26/1995 | WO1995002417A1 Methods for the cultivation of infectious laryngotracheitis virus and egg drop syndrome virus |
| 01/26/1995 | WO1994026730A3 Novel aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents |
| 01/26/1995 | CA2167311A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | CA2167201A1 Amide derivatives of 16-membered ring antibiotic macrolides |
| 01/26/1995 | CA2167042A1 Imidazo[4,5-c]pyridin-4-amines |
| 01/26/1995 | CA2144040A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/25/1995 | EP0635509A2 Novel cephalosporin antibiotics and processes for preparation thereof |
| 01/25/1995 | EP0635132A1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| 01/25/1995 | EP0635062A1 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA |
| 01/25/1995 | EP0635056A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor |
| 01/25/1995 | EP0635026A1 Novel lipophilic oligopeptides with immunomodulating activity |
| 01/25/1995 | EP0634934A1 Method of treatment of hiv-seropositive individuals with dietary whey proteins |
| 01/25/1995 | EP0634927A1 Treatment and prophylaxis of diseases caused by parasites, or bacteria |
| 01/25/1995 | EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression |
| 01/25/1995 | EP0556245B1 Use of thiazolo-isoindolinone derivatives as antiviral medicaments |
| 01/25/1995 | EP0545955B1 Antibiotic ge1655 complex and its factors a, b and c |
| 01/25/1995 | CN1097759A Preparation of parmaceutical compositon containing derivative of 1-pyrrolidinyl-3-chinolon and-naphthyridon carboxylic acid |
| 01/25/1995 | CN1097754A Process for converting loracarbef dihydrate to loracarbef monohydrate |
| 01/25/1995 | CN1097745A 取代的哌嗪 Substituted piperazine |
| 01/25/1995 | CN1097613A Baby "Baotaikang" powder and preparing method |
| 01/24/1995 | US5384326 Bactericides, fungicides |
| 01/24/1995 | US5384134 Anti-inflammatory formulations for inflammatory diseases |
| 01/24/1995 | US5384122 Herpesvirus particles and vaccine |
| 01/19/1995 | WO1995002048A1 Salmonella vaccines |
| 01/19/1995 | WO1995001981A1 Novel substance dc114-a1 |
| 01/19/1995 | WO1995001794A1 Erythromycin derivatives |
| 01/19/1995 | CA2166787A1 Salmonella vaccines |
| 01/19/1995 | CA2165078A1 Erythromycin derivatives |
| 01/19/1995 | CA2143437A1 Novel substance dc114-a1 |
| 01/18/1995 | EP0634436A1 Sulfate of n-acetylneuraminic acid homopolymer, process for producing the same, anti-hiv drug containing said sulfate, method of treating aids with said sulfate, use of said sulfate for treating aids, and use of said sulfate for producing the drug |
| 01/18/1995 | EP0634410A1 Process for the preparation of a N-tert.butylisoquinolin-3-carboxamide derivative and intermediate compounds of these process |
| 01/18/1995 | EP0633942A1 Non-infectious hiv particles and uses therefor |
| 01/18/1995 | EP0633937A1 Immunization by inoculatioon of dna transcription unit |
| 01/18/1995 | EP0633931A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 01/18/1995 | EP0633930A1 In vitro generation of human dendritic cells and uses thereof |
| 01/18/1995 | EP0633887A1 Calanolide antiviral compounds, compositions and uses thereof |
| 01/18/1995 | EP0633884A1 (furan-2-yl)-2-(1-normon-2-yl) oxazole derivatives with antibacterial activity |